No abstract available
Keywords:
Advanced hybrid closed-loop; Cost-effectiveness; Netherlands; Type 1 diabetes.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Blood Glucose
-
Blood Glucose Self-Monitoring
-
Cost-Benefit Analysis
-
Diabetes Mellitus, Type 1* / drug therapy
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Insulin / therapeutic use
-
Insulin Infusion Systems
-
Netherlands
Substances
-
Blood Glucose
-
Hypoglycemic Agents
-
Insulin